CHM — Chimeric Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$0.16m
- -AU$0.64m
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial
Brief: Chimeric Therapeutics Says To Return Chlorotoxin (CHM CLTX) Car T-Cell Therapy Asset
Brief: Chimeric Therapeutics Says Phillip Hains Retires As CFO
Brief: Chimeric Therapeutics Announces A$8.4 MLN Funding To Drive CHM CDH17
Brief: Chimeric Therapeutics Seeks Trading Halt
Brief: Chimeric Therapeutics Says CDH17 Granted FDA Orphan Drug Designation For Gastric Cancer
Brief: Chimeric Therapeutics Receives A$4.5M R&D Tax Incentive
Brief: Chimeric Therapeutics Says Core-Nk + Vactosertib Phase 1B Trial Temporarily Suspended
Australia's Chimeric Therapeutics surges on FDA's 'fast track' tag for neuroendocrine tumour drug
Brief: Chimeric Therapeutics Says CHM CDH17 Receives FDA Fast Track
Australia's Chimeric Therapeutics slides on discounted placement
Brief: Chimeric Therapeutics Announces A$6.6 Mln Placement
Brief: Chimeric Therapeutics Seeks Trading Halt
Brief: Chimeric Therapeutics Seeks Trading Halt
Brief: Chimeric Therapeutics Says US Patent Allowed For CHM CDH17 Technology
Brief: Chimeric Therapeutics To Raise A$3.2 Million